Fibre Laxative - Orange Flavour
Natural health product licensed in Canada
- Other names
- Fibre Laxative
- Licence holder
- Raritan Pharmaceuticals Inc.
- NPN or DIN-HM
- 80094732
- Status
- Active licence
- Licence date
- 4 October 2019
- Revision date
- Not provided
- Form
- Poudre pour suspension
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Sucrose, Silice pyrogénée, Jaune FD&C n° 6, Saveur d'orange, Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Cuillière(s) à table | 3 Tous les jours |
| Adultes et adolescents | minimum: 13 years | 1 Cuillière(s) à table | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 12 years | 0.5 Cuillière(s) à table | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Promotes digestive health or digestive wellness by relieving irregularity. Provides gentle relief of irregularity and /or constipation. Bulk Forming Laxative. Promotes bowel movements by increasing bulk volume and water content. Lowers Cholesterol level. May reduce the risk of coronary heart disease by lowering blood cholesterol levels when used as part of a low-fat, low-cholesterol diet. Promotes heart health. Soluble fibre from psyllium, when included as part of a diet low in saturated fat and cholesterol, may reduce risk of coronary heart disease by lowering cholesterol levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80094732
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.